Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 2 ETFs To Play A Surge In Biotech/Pharma M&A
2 ETFs To Play A Surge In Biotech/Pharma M&A
2 ETFs To Play A Surge In Biotech/Pharma M&A
Submitted by
admin
on January 9, 2012 - 10:39am
Source:
Seeking Alpha
News Tags:
Abbott Laboratories
Amgen
Biogen Idec
Gilead
Celgene
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
Pfizer
ETFs
Headline:
2 ETFs To Play A Surge In Biotech/Pharma M&A
Do Not Allow Advertisers to Use My Personal information
